Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Clinical Journal of the American Society of Nephrology : CJASN|April 15, 2021
Long-Term Immunosuppression Management: Opportunities and UncertaintiesDavid Wojciechowski, Alexander Wiseman
Nature Clinical Practice. Nephrology|March 13, 2008
A case of polyomavirus-associated nephropathy presenting late after transplantationShweta Bansal, M Scott Lucia, Alexander Wiseman
Transplantation Reviews (Orlando, Fla.)|August 13, 2013
Review of combination therapy with mTOR inhibitors and tacrolimus minimization after transplantationV Ram Peddi, Alexander Wiseman, Kenneth Chavin, et al.
JBMR Plus|December 22, 2023
New Human Leukocyte Antigen (HLA) Antibody Formation and Creatinine Elevation With Abaloparatide in Kidney Transplant RecipientChristine M Swanson, Kelly Krohn, Alexander Wiseman, et al.
Advances in Chronic Kidney Disease|November 2, 2020
The Transplant Nephrology Workforce in the United States: Current State and Future DirectionsBeatrice P Concepcion, Sami Alasfar, Swee-Ling Levea, et al.
Transplantation|April 1, 2020
Tacrolimus Intrapatient Variability, Time in Therapeutic Range, and Risk of De Novo Donor-Specific AntibodiesScott Davis, Jane Gralla, Patrick Klem, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 20, 2017
Lower tacrolimus exposure and time in therapeutic range increase the risk of de novo donor-specific antibodies in the first year of kidney transplantationScott Davis, Jane Gralla, Patrick Klem, et al.
Pageof 3